Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$349,656,982
+$151,105,900 QoQ
Shares Held
3,045,262
0.0% QoQ
Ownership
5.21%
of shares outstanding
% of Portfolio
20.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEA Management Company, LLC holds $1,651,836,644 across 23 Biotechnology names. ACLX ranks #1 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
This page
|
3,045,262 | $349,656,982 | |
| 2 | CELC |
Celcuity Inc.
|
2,285,561 | $260,873,932 | |
| 3 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $191,534,518 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $157,741,180 | |
| 5 | SVRA |
Savara Inc
|
24,471,264 | $133,613,101 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $126,538,302 | |
| 7 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $107,892,407 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $78,653,931 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $349,656,982 | 3,045,262 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $198,551,082 | 3,045,262 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $250,016,010 | 3,045,262 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $246,625,502 | 3,745,262 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $245,689,187 | 3,745,262 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $287,224,142 | 3,745,262 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $312,766,829 | 3,745,262 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $206,701,009 | 3,745,262 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $260,482,972 | 3,745,262 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $207,862,041 | 3,745,262 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $134,380,000 | 3,745,262 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $118,425,184 | 3,745,262 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $146,201,522 | 4,745,262 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $147,008,216 | 4,745,262 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $126,702,455 | 6,750,264 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $122,044,773 | 6,750,264 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $90,257,451 | 6,437,764 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||